# MicroRNAs as Biomarkers in First Episode Schizophrenia

> **NCT07703670** · NA · RECRUITING · sponsor: **Northwell Health** · enrollment: 160 (estimated)

## Conditions studied

- Schizophrenia Disorder
- Schizophreniform Disorder
- Schizoaffective Disorder
- Psychosis Not Otherwise Specified (NOS)

## Interventions

- **DIAGNOSTIC_TEST:** Plasma NDE miRNA Sequencing
- **GENETIC:** Whole Genome Sequencing

## Key facts

- **NCT ID:** NCT07703670
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2031-05
- **Final completion:** 2031-05-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703670, "MicroRNAs as Biomarkers in First Episode Schizophrenia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*